Lead Optimization of Positive Allosteric KV7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility

  • J Med Chem. 2025 Apr 24;68(8):8377-8399. doi: 10.1021/acs.jmedchem.4c03112.
Jana Lemke  1 Nadine Mengers  1 Louis Schmidt  1 Lukas Schulig  1 Stefanie König  1 Pascal Rosendahl  1 Frieda-Marie Bartz  1 Ulrike Garscha  1 Patrick J Bednarski  1 Andreas Link  1
Affiliations
  • 1. Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Str. 17, Greifswald 17489, Germany.
Abstract

The voltage-gated Potassium Channel KV7.2/3 is gaining attention for its association with several medical indications. While recently reported, potent compounds aimed to fill the therapeutic gap left by market-withdrawn activators, key physicochemical parameters did not meet the requirements of potential drug candidates. Targeting the membrane-located channel requires subtly balancing lipophilicity, activity, and aqueous solubility. This publication describes the lead optimization of a highly active compound toward optimized physicochemical parameters. Out of 42 newly synthesized compounds, 30 showed activity on KV7.2/3 channels, and 15 had also an increased solubility compared the to hit compound. The integration of a three-dimensional bulky structure and the probable onset of chameleonic behavior, led to a 20-fold solubility increase (S = 21.7 vs 1.1 μM) and only slightly reduced potency (pEC50 = 7.42 vs 7.96) for the lead. Additionally, the target engagement of the compound was theoretically enhanced by a reduction of membrane retention.

Products